医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Open Access Accurate Mass Extractable and Leachable MS/MS Library Developed by SCIEX and Pall Corporation

2022年04月28日 AM12:00
このエントリーをはてなブックマークに追加


 

FRAMINGHAM, Mass.

SCIEX, a global leader in life science analytical technologies, in collaboration with Pall Corporation, a global leader in filtration, separation and purification, launch an open access extractable and leachable (E&L) MS/MS spectral library consisting of 675 compound entries. This library, combined with powerful search algorithms using SCIEX instrumentation and software solutions, enables specific, sensitive and accurate compound identification.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005352/en/

SCIEX, in collaboration with Pall Corporation, launch an open access extractable and leachable (E&L) MS/MS spectral library consisting of 675 compound entries. (Graphic: Business Wire)

SCIEX, in collaboration with Pall Corporation, launch an open access extractable and leachable (E&L) MS/MS spectral library consisting of 675 compound entries. (Graphic: Business Wire)

Scientists need a complete workflow solution that supplies large comprehensive libraries and search algorithms for specific, robust and efficient compound IDs. However, they have challenges with the complexity of E&L ID and confirmation as current libraries lack specific E&L compound spectra, which can lead to false positive and negative results. This library release includes high-quality, accurate mass spectra for relevant chemical species and moieties, allowing for automated, simultaneous ID and quantification. Scientists will be able to maximize confidence in E&L testing workflows while increasing accessibility and reducing overhead.

“Comprehensive characterization from E&L in plastics is essential for exposure and toxicological studies, and the wellness and safety of all. This open access library is part of our commitment to help scientists accelerate their research and make impactful discoveries,” said Jose Castro-Perez, Senior Director of Accurate Mass from SCIEX.

“Together with SCIEX, Pall Biotech’s market-leading advanced extractables and leachables knowledge and experience have contributed to this comprehensive open access library. This will enable end-users to confidently identify E&L compounds during their in-depth analysis. This is especially critical when polymers are in contact with drug substances and excipients during bioprocessing, thus contributing towards enhancing patient safety and wellbeing,” said Wayne Lee, Sr. Director of Global Validation and Laboratory Operations at Pall.

The SCIEX instrument specific E&L library is free to download in the standard SCIEX LibraryView (.lbp) format. SCIEX and Pall also plan a continuous cadence of releases as compounds become commercially available.

To learn more or access the library, see here.

About SCIEX

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have been at the forefront of the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers can quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.

Advances in human wellness depend on the power of precise science.

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

© 2022 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-14671-A.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220427005352/en/

CONTACT

Lulu VanZandt

Senior Manager, Brand, Public Relations and Social Media

lulu.vanzandt@sciex.com

M: +1 (508) 782-9484

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 《新英格兰医学杂志》发表Fazirsiran治疗α-1抗胰蛋白酶缺乏症患者的二期研究结果
  • Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
  • 沃博联结束战略评估,决定保留表现优异的博姿业务
  • BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  • Work for Humankind:联想技术为偏远岛屿开启无限可能